Recode Health Ventures
Overview
Recode Health Ventures is a specialist venture capital firm with offices in San Francisco and London. It invests in seed and series A stage founders who are utilizing emerging deep technology platforms to address challenges in the healthcare sector. The firm's focus is on the convergence of deep tech—such as AI, machine learning, nanotechnology, DNA/RNA technology, and robotics—with healthcare applications in areas like oncology, neuroscience, heart disease, women's health, and surgery.
Portfolio Companies
3
Website
recodeventures.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sensible Biotechnologies | Apr 2023 | Pre Seed | - |
| Nanograb | Jul 2023 | Pre Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Tim Garnett
Equity Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Recode Health Ventures based?
Recode Health Ventures is headquartered in San Francisco, California, United States.
When was Recode Health Ventures founded?
Founding year information for Recode Health Ventures is not publicly available.
How many portfolio companies does Recode Health Ventures have?
Recode Health Ventures has 3 portfolio companies in Caplight's dataset.
What are some companies in Recode Health Ventures's portfolio?
Portfolio companies visible on Caplight include Sensible Biotechnologies, Nanograb.
What was Recode Health Ventures's most recent investment shown here?
Recode Health Ventures's most recent investment in this portfolio sample was in Nanograb in 2023.
What sectors does Recode Health Ventures focus on?
Recode Health Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Recode Health Ventures focus on?
Recode Health Ventures typically invests at the Early stage.